NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmalundensis AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
345
|
307
|
299 |
| Earnings before taxes |
-2,955
|
-2,196
|
-1,897 |
| EBITDA |
-1,920
|
-1,747
|
-1,598 |
| Total assets |
7,364
|
5,854
|
6,042 |
| Current assets |
1,877
|
415
|
825 |
| Current liabilities |
1,782
|
1,581
|
678 |
| Equity capital |
2,122
|
1,173
|
2,325 |
| - share capital |
1,417
|
995
|
1,009 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
28.8%
|
20.0%
|
38.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-35.4%
|
-32.3%
|
-26.4% |
| Current ratio |
105.3%
|
26.2%
|
121.7% |
| Return on equity (ROE) |
-139.3%
|
-187.2%
|
-81.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.